Cloning of the murine re1A (p65 NF-κB) gene and comparison to the human gene reveals a distinct first intron

Gene

Volumn 176, Issue 1-2, 1996, Pages 119-124

  Linker, Ralf A ^a   Baeuerle, Patrick A ^a,b   Kaltschmidt, Christian ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b AMGEN INC   (United States)

Author keywords

AP 1; Intron; NF B; Promoter; Re1A

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL ESTER; PYRROLIDINE DERIVATIVE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; DNA; PHORBOL 13 ACETATE 12 MYRISTATE; PYRROLIDINE DITHIOCARBAMIC ACID; THIOCARBAMIC ACID DERIVATIVE; TRANSCRIPTION FACTOR RELA;

ARTICLE; BINDING SITE; COMPARATIVE STUDY; CONTROLLED STUDY; EXON; GENE INDUCTION; GENE ISOLATION; GENE LOCUS; INTRON; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CHROMOSOME MAP; CYTOLOGY; DRUG EFFECT; FIBROBLAST; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SPECIES DIFFERENCE;

MURINAE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; CHROMOSOME MAPPING; CLONING, MOLECULAR; DNA; FIBROBLASTS; HUMANS; INTRONS; MICE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PYRROLIDINES; SPECIES SPECIFICITY; TETRADECANOYLPHORBOL ACETATE; THIOCARBAMATES; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTOR RELA;

EID: 0030591707     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-1119(96)00231-4     Document Type: Article

References (36)

1. Azizkhan, J.C., Jensen, D.E., Pierce, A.J. and Wade, M. (1993) Transcription from TATA-less promoters: dihydrofolate reductase as a model. Crit. Rev. Euk. Gene Expr. 3, 229-254.
2. Baeuerle, P.A. and Baltimore, D. (1988) IκB: a specific inhibitor of the NF-κB transcription factor. Science 242, 540-546.
3. Baeuerle, P.A. and Henkel, T. (1994) Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141-179.
4. Beg, A.A., Sha, W.C., Bronson, R.T., Gosh, S. and Baltimore, D. (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376, 167-170.
5. Deloukas, P. and van Loon A. (1993) Genomic organization of the gene encoding the p65 subunit of NF-κB. Multiple variants may be generated by alternative splicing. Hum. Mol. Gen. 11, 1895-1900.
6. Grimm, S. and Baeuerle, P.A. (1993) The inducible transcription factor NF-κB: structure/function relationship of its protein subunits. Biochem. J. 290, 297-308.
7. Hannink, M. and Temin H.M. (1990) Structure and autoregulation of the c-rel promoter. Oncogene 5, 1843-1850.
8. Kaltschmidt, C., Kaltschmidt, B. and Baeuerle, P. A. (1993) Brain synapses contain inducible forms of the transcription factor NF-κB. Mech. Dev. 43, 135-147.
9. Kaltschmidt, C., Kaltschmidt, B., Lannes-Vieira, J., Kreutzberg, G.W., Wekerle, H., Baeuerle, P.A. and Gehrmann, J. (1994a) Activation of transcription factor NF-κB in microglia during experimental autoimmune encephalomyelitis. J. Neuroimmunol. 55, 99-106.
10. Kaltschmidt, C., Kaltschmidt, B., Neumann, H., Wekerle, H. and Baeuerle, P.A. (1994b) Constitutive NF-κB activity in neurons. Mol. Cell. Biol. 14, 3981-3992.
11. Kaltschmidt, C., Kaltschmidt, B. and Baeuerle, P.A. (1995) Activation of ionotropic glutamate receptors activates transcription factor NF-κB in primary neurons. Proc. Natl. Acad. Sci. USA 92, 9618-9622.
12. Köntgen, F., Grumont, R.J., Strasser, A., Metcalf, D., Ei, R., Tarlinton, D. and Gerondakis, S. (1995) Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity and interleukin-2 expression. Gen. and Dev. 9, 1965-1977.
13. Kozak, M. (1989) The scanning model for translation: an update. J. Cell. Biol. 108, 229-241.
14. Lee, T.C., Shi, Y. and Schwartz, R.J. (1992) Displacement of BrdUrd-induced YY1 by serum response factor activates α-actin transcription in embryonic fibroblasts. Proc. Natl. Acad. Sci. USA. 89, 9814-9818.
15. Lee, W., Mitchell, P. and Tjian R. (1987) Purified transcription factor AP-1 interacts with TPA-inducible elements. Cell 49, 741-752.
16. Liou, H.C. and Baltimore, D. (1993) Regulation of the NF-κB/rel transcription factor and IκB inhibitor system. Curr. Opin. Cell. Biol. 5, 477-487.
17. Liou, H.C., Sha, W.C., Scott, M.L. and Baltimore, D. (1994) Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation. Mol. Cell. Biol. 14, 5349-5359.
18. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12, 2005-2015.
19. Nolan, G.P., Ghosh, S., Liou, H.-C., Tempst, P. and Baltimore, D. (1991) DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell 64, 961-969.
20. Perkins, N.D., Schmid, R.M., Duckett, L.S., Leung, K., Rice, N.R. and Nabel, G.J. (1992) Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation. Proc. Natl. Acad. Sci. USA. 89, 1529-1533.
21. Rousseau, G.G. (1992) Growth hormone gene regulation by transacting factors. Hormone Res. 37 Suppl., 88-92.
22. Ruben, S.M., Dillon, P.J., Schreck, R., Henkel, T., Chen, C.-H., Maher, M., Baeuerle, P.A. and Rosen, C. (1991) Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-κB. Science 251, 1490-1493.
23. Sauer, B. and Henderson, N. (1988) Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. USA 85, 5166-5170.
24. Schenk, H., Klein, M., Erdbrügger, W., Dröge, W. and Schulze-Osthoff, K. (1994) Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc. Natl. Acad. Sci. USA. 85, 1672-1676.
25. Schmitz, M.L. and Baeuerle, P.A. (1991) The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 10, 3805-3817.
26. Schmitz, M.L., dos Santos Silva, M.A., Altmann, H., Czisch, M., Holak, T.A. and Baeuerle, P.A. (1994) Structural and functional analysis of the NF-kappa B p65 C-terminus. An acidic and modular transactivation domain with the potential to adopt an alpha-helical conformation. J. Biol. Chem. 269, 25613-25620.
27. Schreck, R., Rieber, P. and Baeuerle, P.A. (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10, 2247-2258.
28. Sen, R. and Baltimore, D. (1986) Multiple nuclear factors interact with the immuno-globulin enhancer sequences. Cell 46, 705-716.
29. Sha, W.C., Liou, H.-C., Tuomanen, E.I. and Baltimore, D. (1995) Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80, 321-330.
30. Siebenlist, U., Franzoso, G. and Brown, K. (1994) Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10, 405-455.
31. Ten, R.M., Paya, C.V., Israel, N., Le Bail, O., Mattei, M.G., Virelezier, J.L., Kourilsky, P. and Israel, A. (1992) The characterization of the promoter of the gene encoding the p50 subunit of NF-κB indicates that it participates in its own regulation. EMBO J. 11, 195-203.
32. Traenckner, E.B.-M., Wilk, S. and Baeuerle, P.A. (1994) A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J. 13, 5433-5441.
33. Traenckner, E.B.-M., Pahl, H.L., Henkel, T., Schmidt, K.N., Wilk, S. and Baeuerle, P.A. (1995) Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14, 2876-2883.
34. Ueberla, K., Lu, Y., Chung, E. and Haseltine, W.A. (1993) The NF-kappa B p65 promoter. J. Acq. Imm. D. 6, 227-230.
35. Weih, F., Carrasco, D., Durham, S.K., Barton, D.S., Rizzo, C.A., Ryseck, R.-P., Lira, S.A. and Bravo, R. (1995) Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell, 80, 331-340.
36. Wilhelmsen, J.C., Eggleton, K. and Temin, H.M. (1984) Nucleic acid sequences of the oncogene v-rel in reticuloendotheliosis virus strain T and its cellular homolog, the proto-oncogene c-rel. J. Virol. 52, 172-182.